Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes

Nuclear Medicine and Biology

Volumn 32, Issue 7, 2005, Pages 733-740

  Smith, Charles J ^a,b,c   Volkert, Wynn A ^b,c   Hoffman, Timothy J ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c University of Missouri   (United States)

Author keywords

Bombesin

Indexed keywords

BOMBESIN; BOMBESIN RECEPTOR; GASTRIN RELEASING PEPTIDE RECEPTOR;

AQUEOUS SOLUTION; ARTICLE; BREAST CARCINOMA; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; ISOTOPE LABELING; LUNG SMALL CELL CANCER; MEDICAL RESEARCH; NONHUMAN; PROSTATE CARCINOMA;

EID: 27144533633     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2005.05.005     Document Type: Review

References (52)

1. C.J. Smith, W.A. Volkert, and T.J. Hoffman Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update Nucl Med Biol 30 2003 861 868
2. E.R. Spindel, E. Giladi, P. Brehm, R.H. Goodman, and T.P. Seferson Cloning and functional characterization of a complementary DNA encoding the murine fibroblast bombesin/gastrin-releasing peptide receptor Mol Endocrinol 4 1990 1956 1963
3. J.F. Battey, J.M. Way, M.H. Corjay, K. Kusano, R. Harkins, and J.M. Wu Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells Proc Natl Acad Sci U S A 88 2 1991 395 399
4. T. Von Schrenck, P. Heinz-Erian, T. Moran, S.A. Mantey, J.D. Gardner, and R.T. Jensen Neuromedin B receptor in oesophagus: evidence for subtypes of bombesin receptors Am J Physiol 256 1989 G747 G758
5. E. Wada, J. Way, H. Shapira, K. Kusano, A.M. Lebacq-Verheyden, and D. Coy cDNA cloning, characterization, and brain region-specific expression of a neuromedin B-preferring bombesin receptor Neuron 6 3 1991 421 430
6. 13]bombesin distinct from the receptor for gastrin-releasing peptide: identification of a fourth bombesin receptor subtype (BB4) Proc Natl Acad Sci U S A 92 1995 6205 6209
7. Z. Fathi, M.H. Corjav, H. Shapira, E. Wada, R. Benya, and R. Jensen BRS-3: novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells J Biol Chem 268 8 1993 5979 5984
8. T.K. Pradhan, T. Katsuno, J.E. Taylor, S.H. Kim, R.R. Ryan, and S.A. Mantey Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes Eur J Pharm 343 1998 275 287
9. A. Anastasi, V. Erspamer, and M. Nucci Isolation and amino acid sequences of alytesin and bombesin, two analogous active tetradecapeptides from the skin of European discoglossid frogs Arch Biochem Biophys 148 2 1972 443 446
10. 2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies Anticancer Res 23 2003 63 70
11. K.E. Baidoo, K.-S. Lin, Y. Zhan, P. Finley, U. Scheffel, and H.N. Wagner Jr Design, synthesis, and initial evaluation of high-affinity technetium bombesin analogues Bioconjug Chem 9 1998 218 225
12. 188Re of peptide conjugates containing a dithia-bisphosphine chelating agent Bioconjug Chem 12 2001 354 363
13. 99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent Bioconjug Chem 10 1999 254 260
14. 2: an in vitro/in vivo structure-activity relationship study where X=0, 3, 5, 8, and 11-carbon tethering moieties Bioconjug Chem 14 2003 93 102
15. C. Van de Wiele, F. Dumont, R.V. Broecke, W. Oosterlinck, V. Cocquyt, and R. Serreyn Technetium-99m RP525, a GRP analogue for visualization of GRP receptor-expressing malignancies: a feasible study Eur J Nucl Med 27 2000 1694 1699
16. 99mTc-RP-527, a gastrin releasing peptide (GRP) analogue for visualization of GRP receptor expressing malignancies: a feasibility study Nucl Med Commun 2000 21
17. 99mTc] Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging Eur J Nucl Med 30 2 2003 247 258
18. 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors Nucl Med Biol 29 2002 553 560
19. 3 Cancer Res 63 2003 4082 4088
20. B.E. Rogers, M.W. Brechbiel, R.L. Kirkman, M. Clarkson, and D.J. Buchsbaum In vitro binding and internalization of an indium-111 labeled bombesin derivative to cells expressing the gastrin releasing peptide receptor M. Nicolini U. Mazzi Technetium, rhenium and other metals in chemistry and nuclear medicine 1999 SGE Editoriali Italy 519 525
21. W.A.P. Breeman, L.J. Hofland, M. DeJong, B.F. Bernard, A. Srinivasan, and D.J. Kweekeboom Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy Int J Cancer 81 1999 658 665
22. H. Zhang, J. Chen, C. Waldherr, K. Hinni, B. Waser, and J.C. Reubi Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors Cancer Res 64 2004 6707 6715
23. 177Lu-AMBA, a DOTA conjugate that targets GRP and NMB receptor expressing tumors: internalization, in vivo biodistribution, single dose radiotherapy in PC-3 tumor-bearing nude mice and in vitro autoradiography in animal and human tissues 2004 EANM Helsinki (Finland)
24. A. Fleischmann, U. Laderach, H. Friess, M.W. Buechler, and J.C. Reubi Bombesin receptors in distinct tissue compartments of human pancreatic diseases Lab Invest 80 12 2000 1807 1817
25. H. Sano, S.D. Feighner, D.L. Hreniuk, H. Iwaasa, A.W. Sailer, and J. Pan Characterization of the bombesin-like peptide receptor family in primates Genomics 84 2004 139 146
26. C. Van De Wiele, F. Dumont, S. Van Belle, G. Slegers, S.H. Peers, and R.A. Dierckx Is there a role for agonist gastrin-releasing peptide receptor radioligands in tumor imaging? Nucl Med Commun 22 2001 5 15
27. S. Jurisson, D. Berning, W. Jia, and F. Ma Coordination compounds in nuclear medicine Chem Rev 93 1993 1137 1156
28. 99mTc-labeled peptides Q J Nucl Med 46 2002 195 205
29. 99mTc-labeled small peptides as diagnostic radiopharmaceuticals Chem Rev 99 1999 2235 2268
30. K.-S. Lin, A. Luu, K.E. Baidoo, H. Hashemzadeh-Gargari, M.K. Chen, and K. Brenneman A new high affinity technetium-99m-bombesin analogue with low abdominal accumulation Bioconjug Chem 16 2005 43 50
31. 99mTc, Re): synthesis, characterization and biological behaviour Bioconjug Chem 16 2005 438 449
32. 2: radiochemical evaluation with co-ligands EDDA (EDDA=ethylenediamine-N,N′- diacetic acid), tricine, and nicotinic acid Synt React Inorg Met-Org Nano-Met Chem 35 2005 43 51
33. K.R. Zinn, C.A. Smith, Q. Wu, R.L. Kirkman, J.M. Mountz, and D.J. Buchsbaum Imaging adenoviral-mediated gene transfer of gastrin releasing peptide receptor (GRPr) using a Tc-99m-labeled bombesin (BBN) analogue J Nucl Med 39 1998 224P [abstract 994]
34. M.F. Giblin, B. Veerendra, and C.J. Smith Radiometallation of receptor-specific peptides for diagnosis and treatment of human cancer In Vivo 19 2005 9 30
35. 99mTc: a preclinical study J Med Chem 48 1 2005 100 110
36. C.S. Cutler, C.J. Smith, G.L. Ehrhardt, T.T. Tyler, S.S. Jurisson, and E. Deutsch Current and potential therapeutic uses of lanthanide radioisotopes Cancer Biother Radiopharm 15 6 2000 531 545
37. S.A. Mantey, H.C. Weber, and E. Sainz Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors J Biol Chem 272 1997 26062 26071
38. 177Lu-AMBA; a radiotherapeutic compound that targets gastrin releasing peptide receptors 2004 EANM Helsinki (Finland)
39. 177Lu-DOTA conjugate for targeting of tumors expressing gastrin releasing peptide receptors (GRP-R) J Nucl Med 45 5 2004 169P [abstract 482]
40. 90Y-DOTA-peptide-ChL6 Prostate 50 1 2002 27 37
41. 2 combined with chemotherapy in androgen independent human prostate tumor cell xenografted SCID mice Clin Cancer Res 2005 [submitted for publication]
42. D.M. Savarese, S. Halabi, and V. Hars Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and leukemia group B J Clin Oncol 26 5 Suppl. 17 1999 45 48
43. K. Fukuoka, and N. Saijo Antimitotic agents Jpn J Cancer Chemother 24 11 1997 1519 1525
44. P.O. Gunnarsson, and G.P. Forshell Clinical pharmacokinetics of estramustine phosphate Urology 23 6 Suppl. 1984 22 27
45. 2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells Nucl Med Biol 30 2 2003 101 109
46. T.J. Hoffman, C.J. Smith, and N.K. Owen Lu-177 radiolabeled peptides for targeted radiotherapy of androgen independent prostate cancer 94th Annu AACR Proc 44 2 2003 1292
47. 3]bombesin in human prostate adenocarcinoma xenografts J Nucl Med 45 2004 1390 1397
48. C.J. Anderson, and M.J. Welch Radiometal-labeled agents (non-technetium) for diagnostic imaging Chem Rev 99 1999 2219 2234
49. 67Cu 2004 EANM Helsinki (Finland)
50. 64Cu-labeled polyethylene glycol-bombesin conjugate Cancer Biother Radiopharm 19 2004 25 34
51. S.J. Knox, and R.F. Meredith Clinical radioimmunotherapy Semin Radiat Oncol 10 2000 73
52. H. Maecke, H. Zhang, and M. Walter Metabolically stabilized DOTA-bombesin based peptides by amino acid modification in position 11 2004 EANM Helsinki (Finland)